Nuvation Bio Inc.
NUVB
Price:
$2.67
Market Cap:
$898.63M
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti...[Read more]
Industry
Biotechnology
IPO Date
2020-08-26
Stock Exchange
NYSE
Ticker
NUVB
PE Ratio
[-1.22]
ROE
[-108.68%]
Current Ratio
[9.57]
Dividend Yield
[0%]
Enterprise Value
[879.79M]
Dividend History
The ROE as of December 2024 (TTM) for Nuvation Bio Inc. (NUVB) is -108.68%
According to Nuvation Bio Inc.’s latest financial reports and current stock price. The company's current ROE is -108.68%. This represents a change of 125.49% compared to the average of -48.20% of the last 4 quarters.
Nuvation Bio Inc. (NUVB) Historical ROE (quarterly & annually)
How has NUVB ROE performed in the past?
The mean historical ROE of Nuvation Bio Inc. over the last ten years is 8.29%. The current -108.68% ROE has changed -1411.36% with respect to the historical average. Over the past ten years (40 quarters), NUVB's ROE was at its highest in in the March 2019 quarter at 1.25%. The ROE was at its lowest in in the June 2024 quarter at -179.82%.
Average
8.29%
Median
-13.03%
Minimum
-28.49%
Maximum
133.33%
Nuvation Bio Inc. (NUVB) ROE by Quarter and Year
Discovering the peaks and valleys of Nuvation Bio Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 26.63%
Maximum Annual ROE = 133.33%
Minimum Annual Increase = -121.37%
Minimum Annual ROE = -28.49%
| Year | ROE | Change |
|---|---|---|
| 2023 | -12.53% | -7.45% |
| 2022 | -13.53% | 26.63% |
| 2021 | -10.69% | -41.79% |
| 2020 | -18.36% | -35.56% |
| 2019 | -28.49% | -121.37% |
Nuvation Bio Inc. (NUVB) Average ROE
How has NUVB ROE performed in the past?
The current ROE of Nuvation Bio Inc. (NUVB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-12.25%
5-year avg
-16.72%
10-year avg
8.29%
Nuvation Bio Inc. (NUVB) ROE vs. Peers
How is NUVB’s ROE compared to its peers?
Nuvation Bio Inc.’s ROE is greater than Assembly Biosciences, Inc. (-121.46%), greater than Instil Bio, Inc. (-37.44%), greater than Achilles Therapeutics plc (-54.57%), greater than NextCure, Inc. (-62.50%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than CytomX Therapeutics, Inc. (-41.34%), less than Spero Therapeutics, Inc. (3.36%),
| Company | ROE | Market cap |
|---|---|---|
| -121.46% | $94.84M | |
| -37.44% | $141.74M | |
| -54.57% | $40.33M | |
| -62.50% | $26.35M | |
| -8.54% | $8.20M | |
| -41.34% | $85.30M | |
| 3.36% | $50.31M |
Build a custom stock screener for Nuvation Bio Inc. (NUVB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvation Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nuvation Bio Inc. (NUVB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nuvation Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nuvation Bio Inc.'s ROE?
How is the ROE calculated for Nuvation Bio Inc. (NUVB)?
What is the highest ROE for Nuvation Bio Inc. (NUVB)?
What is the 3-year average ROE for Nuvation Bio Inc. (NUVB)?
What is the 5-year average ROE for Nuvation Bio Inc. (NUVB)?
How does the current ROE for Nuvation Bio Inc. (NUVB) compare to its historical average?